Pluri Inc. Files 8-K: Agreements, Equity Sales, Officer Changes
Ticker: PLUR · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1158780
| Field | Detail |
|---|---|
| Company | Pluri Inc. (PLUR) |
| Form Type | 8-K |
| Filed Date | Jan 29, 2025 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.00001, $4.61, $0.0001, $5.568, $6.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, officer-changes
TL;DR
Pluri Inc. signed a deal, sold some stock, and shuffled execs. Check the 8-K.
AI Summary
Pluri Inc. announced on January 23, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and changes in its board and officer composition, including compensatory arrangements. The filing was made on January 29, 2025.
Why It Matters
This 8-K filing indicates significant corporate actions at Pluri Inc., including new agreements and potential equity dilution, which could impact investors.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- Pluri Inc. (company) — Filer of the 8-K report
- January 23, 2025 (date) — Earliest event date reported
- January 29, 2025 (date) — Date of report filing
FAQ
What type of material definitive agreement did Pluri Inc. enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What was the date of the earliest event reported in the 8-K?
The earliest event reported was on January 23, 2025.
When was the 8-K report filed by Pluri Inc.?
The report was filed on January 29, 2025.
What other items are covered in this 8-K filing besides the material definitive agreement?
The filing also covers unregistered sales of equity securities and departure/election of directors and officers, along with compensatory arrangements.
What is Pluri Inc.'s Standard Industrial Classification?
Pluri Inc.'s Standard Industrial Classification is BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
Filing Stats: 2,060 words · 8 min read · ~7 pages · Grade level 14.2 · Accepted 2025-01-29 08:53:14
Key Financial Figures
- $0.00001 — h registered Common Shares, par value $0.00001 per share PLUR The Nasdaq Capital M
- $4.61 — purchase price for each Common Share is $4.61. The Pre-Funded Warrants have an exerci
- $0.0001 — nded Warrants have an exercise price of $0.0001 per share, are exercisable at any time
- $5.568 — mmon Warrants have an exercise price of $5.568 per share, will not be exercisable unti
- $6.5 million — fering are expected to be approximately $6.5 million. The Company intends to use the proceed
- $4.5 m — o"), for an aggregate purchase price of $4.5 million, payable in Common Shares (the "K
- $500,000 — lt in liabilities to Kokomodo exceeding $500,000, then the Company shall (a) purchase a
- $1,000,000 — es in Kokomodo for a purchase amount of $1,000,000 (based on a $6,000,000 pre-money valuat
- $6,000,000 — rchase amount of $1,000,000 (based on a $6,000,000 pre-money valuation of Kokomodo, calcul
- $5,500,000 — komodo and a pre-money valuation cap of $5,500,000 in connection with such conversion. 1
Filing Documents
- ea0228987-8k_pluri.htm (8-K) — 42KB
- ea022898701ex4-1_pluri.htm (EX-4.1) — 78KB
- ea022898701ex4-2_pluri.htm (EX-4.2) — 78KB
- ea022898701ex10-1_pluri.htm (EX-10.1) — 269KB
- ea022898701ex10-2_pluri.htm (EX-10.2) — 51KB
- 0001213900-25-007698.txt ( ) — 806KB
- plur-20250123.xsd (EX-101.SCH) — 3KB
- plur-20250123_lab.xml (EX-101.LAB) — 33KB
- plur-20250123_pre.xml (EX-101.PRE) — 22KB
- ea0228987-8k_pluri_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PLURI INC. Date: January 29, 2025 By: /s/ Liat Zalts Name: Liat Zalts Title: Chief Financial Officer 4